Search
for
Sort by
Research 421–450 of 1000+
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- Specific interpretation of hair concentrations in 2 fatal metformin intoxication cases
- Side effects after artificial hair implants: 2 case reports
- Cashmere growth control in Liaoning cashmere goat by ovarian carcinoma immunoreactive antigen-like protein 2 and decorin genes
- The Osler Lecture 2012 'Pharmacology 2.0, medicines, drugs and human enhancement'
- Telogen effluvium in SARS‐CoV‐2 infection: Histological aspects
- Exploring the Potential of DALL-E 2 in Pediatric Dermatology: A Critical Analysis
- An atypical clinical presentation of alopecia in 2 patients with systemic lupus erythematosus
- Hutchinson-Gilford progeria syndrome: Report of 2 cases and a novel LMNA mutation of HGPS in China
- The Belgian Ten‐Center Open Label Trial of Topical 2% Minoxidil Solution in Early Male Pattern Alopecia
- The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies
- Identification of key genes in type 2 diabetes‐induced erectile dysfunction rats with stem cell therapy through high‐throughput sequencing and bioinformatic analysis
- Genetic and hormonal influence on SARS-CoV-2-infection susceptibility
- Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation
- Use of a modified hair strand test to assess the antifungal activity kinetics of dog hair after a 2% climbazole shampoo application
- The Correlation between Periodontal Diseases and Chronological Age among Type 2 Diabetes Mellitus Patients attending at National Healthcare Network (NHN) Mirpur Centre, Dhaka, Bangladesh
- Feline immune-mediated skin disorders: Part 2
- Woodhouse-Sakati Syndrome: The New Genetic Variant of DCAF17 In 2 Adult Sisters
- EFFICACY AND SAFETY OF ORAL MINOXIDIL 2.5 MG ONCE DAILY IN MEN WITH ANDROGENETIC ALOPECIA: PROSPECTIVE SINGLE-CENTRE STUDY
- Supporting data for "Microneedle Frequency Adjunct to 2% Minoxidil in Female androgenetic alopecia: A Randomized Controlled Trial"
- Supporting data for "Microneedle Frequency Adjunct to 2% Minoxidil in Female androgenetic alopecia: A Randomized Controlled Trial"
- Lipid-based nanocarriers coupled with CO 2 laser-mediated drug delivery enhance skin penetration and hair follicle targeting
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- Peer Review #7 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.2)"
- Peer Review #6 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.2)"
- Effect of oral minoxidil 1 mg and 2.5 mg on the growth speed of hair and nails
- Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice
- The G-Protein Couple Receptor Kinase 2 (GRK2) Orchestrates Hair Follicle Homeostasis